Document Detail


Effect of smoking status on outcome after acute ischemic stroke.
MedLine Citation:
PMID:  16446540     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The status of smoking as a risk factor for the occurrence of stroke is well established. However, there is a paucity of data on the relationship between smoking status and acute stroke outcomes. We evaluated the role of recent smoking as a prognostic factor following acute ischemic stroke. METHODS: We analyzed data from patients enrolled in the Intravenous Magnesium Efficacy in Stroke (IMAGES) trial. Outcome measures studied included change in IMAGES stroke score, poor functional outcomes at day 30 and 90 (defined as Rankin Scale >1 and Barthel Index <95), and survival over the first 3 months after stroke. The independent effect of smoking status (subjects who had smoked in the past year) on outcome was evaluated by logistic regression analysis and Cox's proportional hazards model, adjusting for variables known to predict outcome after ischemic stroke. RESULTS: There were 2,386 subjects in the IMAGES efficacy dataset, including 615 recent or current smokers and 1,771 nonsmokers, among whom smokers were younger (p < 0.0001). After adjusting for covariates, smokers had increased odds of poor 90-day functional outcome independently of other statistically significant predictor variables, as assessed by Rankin Scale (odds ratio 1.38; 95% confidence interval 1.09-1.75) and Barthel Index (odds ratio 1.42; 95% confidence interval 1.13-1.79) at day 90. Smoking status did not affect survival at day 90. CONCLUSIONS: Current or recent smokers experience poorer functional outcomes than nonsmokers 3 months after acute ischemic stroke.
Authors:
Bruce Ovbiagele; Christopher J Weir; Jeffrey L Saver; Keith W Muir; Kennedy R Lees;
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-01-27
Journal Detail:
Title:  Cerebrovascular diseases (Basel, Switzerland)     Volume:  21     ISSN:  1015-9770     ISO Abbreviation:  Cerebrovasc. Dis.     Publication Date:  2006  
Date Detail:
Created Date:  2006-03-14     Completed Date:  2006-05-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9100851     Medline TA:  Cerebrovasc Dis     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  260-5     Citation Subset:  IM    
Affiliation:
Stroke Center and Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA. ovibes@mednet.ucla.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Brain Ischemia / drug therapy*,  physiopathology
Female
Humans
Magnesium Sulfate / therapeutic use*
Male
Middle Aged
Neuroprotective Agents / therapeutic use*
Randomized Controlled Trials as Topic
Smoking* / physiopathology
Stroke / drug therapy*,  physiopathology
Treatment Outcome
Chemical
Reg. No./Substance:
0/Neuroprotective Agents; 7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Decreased frequencies of ABCA1 polymorphisms R219K and V771M in Hungarian patients with cerebrovascu...
Next Document:  Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselecte...